10/3/2022 10:24 AM
Myovant Sciences Ltd (NYSE:MYOV) stock is soaring today, up 35.7% at $24.48 at last glance, after the biopharmaceutical name rejected a buyout offer from Japan-based Sumitomo Pharma. Myovant said that...
12/28/2020 10:40 AM
The shares of Myovant Sciences Ltd (NYSE:MYOV) are up 27.2% at $29.08 at last check, gapping to record highs, after the biopharmaceutical concern announced a collaboration with Pfizer (PFE) to develo...
11/19/2019 11:56 AM
Stocks hit new record highs out of the gate as traders cheered news of Boeing's (BA) Dubai Air Show 737 Max jet orders and upbeat housing data. However, the Dow Jones Industrial Average (DJI) and ...
11/19/2019 10:06 AM
At the top of the Nasdaq this morning sits U.K.-based biotech Myovant Sciences Ltd (NYSE:MYOV), up 141% to trade at $14.62. Powering today's breakout is relugolix, the company's treatment for advanced...